TY  - GEN
AU  - Rosenberg,Jonathan E
AU  - Small,Eric J
TI  - Second-line chemotherapy for hormone-refractory prostate cancer: has the time come?
SN  - 1540-0352
PY  - 2004///1209
KW  - Aged
KW  - Androgen Antagonists
KW  - adverse effects
KW  - Clinical Trials, Phase III as Topic
KW  - Docetaxel
KW  - Drug Resistance, Neoplasm
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Mitoxantrone
KW  - administration & dosage
KW  - Neoadjuvant Therapy
KW  - Neoplasm Staging
KW  - Prognosis
KW  - Prostate-Specific Antigen
KW  - blood
KW  - Prostatic Neoplasms
KW  - drug therapy
KW  - Randomized Controlled Trials as Topic
KW  - Risk Assessment
KW  - Survival Analysis
KW  - Taxoids
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.3816/cgc.2004.n.022
ER  -